Objective: To estimate in-hospital, 1-yr, and long-term mortality and to assess time trends in incidence and outcomes of sepsis admissions in the intensive care unit.
S epsis is an ongoing cause of mortality and morbidity. More than a decade ago, a consensus committee of the American College of Chest Physicians and the Society of Critical Care Medicine defined the disorder as the systemic inflammatory response to the presence of infection which, when severe, is accompanied by organ dysfunction or hypotension (1) .
Despite the progress in early diagnosis and advanced treatment options (2) (3) (4) , severe sepsis continues to be a disease with a high mortality rate (5, 6) . With the aging of Western populations, the success in treatment and prevention of previously lethal cardiovascular and infectious diseases, and improvements in preventive medicine, the incidence of sepsis and severe sepsis, as a major common pathway for end-of-life events, has increased (6) and is expected to increase further.
Patients with severe sepsis comprise 10%-40% of intensive care unit (ICU) admissions (7) . Mortality from sepsis has recently been shown to be decreasing; however, despite sophisticated diagnostic and treatment modalities, severe sepsis mortality remains unacceptably high (8 -11) . The care of patients with severe sepsis therefore poses a significant economic burden on the healthcare system (5, 12) . In the United States, it has been estimated that in-hospital care for these patients requires an average of 20 hospital days, involves ICU admission in more than half of the patients, and results in hospital costs exceeding $16 billion annually (13) . Finally, survivors of sepsis face a reduced long-term quality of life (14 -18) .
Research into the epidemiology of sepsis has traditionally focused on shortterm outcome and was conducted mainly in the United States. Contemporary, large, population-based nationwide studies are scarce, and the long-term prognosis of severe sepsis was evaluated only in a small number of studies (17) (18) (19) (20) .
We conducted a computerized database study of patients hospitalized with sepsis in the ICUs of seven major tertiary hospitals in Israel between January 2002 and December 2008. The study goals were to estimate in-hospital, 1-yr, and long-term mortality, and to assess time trends in incidence and outcomes of ICU sepsis admissions.
METHODS
The study was approved by the institutional review board of Soroka University Medical Center, Beer Sheva, Israel, and informed consent was waived. The study included all adult patients (aged 18 yrs or older) admitted or transferred to the general, surgical, medical, or respiratory ICU (but not cardiac ICU) and diagnosed with sepsis between January 2002 and December 2008 in seven general hospitals operated by Clalit Health Services ("Clalit"). Clalit is the major health plan in Israel with 4 million enrollees. According to the National Health Insurance Law enacted in 1995, all Israeli citizens and permanent residents are entitled to universal health insurance and are free to choose among one of four health plans, which operate similar to Health Maintenance Organizations in the United States. In addition to offering primary care and ambulatory services, Clalit operates eight general tertiary care hospitals, all of which are teaching hospitals, with approximately 4,400 beds (including adult ICU beds half of which are general noncoronary beds). That represents one third of all acute-care hospital beds in Israel. These hospitals offer inpatient services to all Israeli citizens, regardless of the health plan in which they are enrolled. Of these eight hospitals, seven were included in the present analysis, since one hospital does not have an ICU. For the present study, the central data warehouse of Clalit's hospitals was utilized. The data warehouse collects data from all clinical and administrative data systems, including the admission-transferdischarge administrative database, operating room database, logistics, imaging, laboratory data, and discharge diagnoses.
Patients diagnosed with sepsis were identified by searching the Clalit's database for admissions with a diagnosis of sepsis (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 003.1, 036.2, 038.0 -9, 112.5, 785.52, 790.7, and 995.91-92). This definition has been used extensively in population-based and hospitalbased studies of sepsis. Furthermore, validation data suggest a sensitivity of 88% (21) , and positive predictive values of 89% for confirmed sepsis, and 98% for severe sepsis (22) . For the purpose of this study, only the first episode of sepsis that occurred for each patient during the study period was included. For the definition of severe sepsis, ICD-9-CM codes indicative of diagnoses presumed to represent acute organ failure were applied, as described by Martin The following variables were collected from the computerized database of Clalit's hospitals: admitting department (ICU, internal medicine, surgery); in-hospital transfers during hospitalization (ICU, internal medicine, other); dates of hospital admission; transfer to ICU and hospital discharge, or alternatively, death; site of infection and organisms identified in blood cultures (according to ICD-9-CM codes); death date; demographics (age, sex, ethnicity); all diagnoses during the index hospitalization as recorded by ICD-9-CM; and Charlson comorbidity index (based on ICD-9-CM codes of chronic diagnoses, presumably diagnosed before admission and listed during hospitalization, automatically calculated within the computerized database). The primary outcomes were in-hospital mortality and long-term survival. Data regarding long-term survival was available only for Clalit's enrollees and retrieved from Clalit's primary care database. For comparison with the general Clalit population, age-specific mortality rates for 2010 were retrieved from the same database.
Statistical Analysis
Data analysis was performed using SPSS version 18 (SPSS, Chicago, IL). Data were summarized using frequency tables for categorical variables and summary statistics (median, mean and SD) for continuous variables. Categorical variables were compared using chi-square tests. Continuous variables were compared using t tests or analysis of variance. For continuous variables with a non-normal distribution, comparisons were made using the nonparametric Wilcoxon rank-sum test.
Long-term survival was compared between strata of age, Charlson comorbidity index, and the number of failing organ systems using Kaplan-Meier's method. Log-rank test was used to assess the significance of the difference in survival. Indirect age adjustment was used to compare the observed 1-yr mortality among sepsis survivors to the expected 1-yr mortality based on rates in the general population. p values Ͻ.05 were considered statistically significant for all comparisons. All reported p values are two sided.
RESULTS
During the study period, 27,516 patients were diagnosed with sepsis. Of these, 1,091 (4.0%) were directly admit-ted to the ICU, 2,096 (7.6%) were first admitted to an internal medicine ward and later transferred to the ICU, and 1,968 (7.2%) were first admitted to a surgical ward (or the operating room) and later transferred to the ICU. Overall, 5,155 patients were eventually admitted to the ICU and included in the study. These patients comprise 18.7% of the patients with sepsis. The proportion of patients admitted to the ICU among patients with sepsis, severe sepsis, and septic shock were 3.8%, 29%, and 36%, respectively. The rest of the patients were treated in general medical or surgical wards.
Baseline characteristics of the patients are given in Table 1 . The patients' median age was 70. Most patients (56%) were male. The most common comorbidities were hypertension (50%), chronic ischemic heart disease (34%), and diabetes (33%). Using ICD-9-CM codes, the site of infection could be identified as pulmonary in 34%, the urinary tract in 12%, soft tissues in 5%, the gastrointestinal tract in 4%, and the peritoneal cavity in 12%. In the rest of the patients (33%), the source of the infection could not be determined from ICD-9-CM codes. Based on the algorithm described by Martin et al (8) , 9% had no organ failure, while 31%, 31%, and 30% had one, two, or three or more failing organ systems, respectively (Table 1) .
Over time, the number of sepsisrelated ICU admissions increased linearly by 37%, from a mean of 49 per month in 2002 to 67 in 2008 ( Fig. 1A) . The R 2 for a linear association between the period of admission and the number of admissions per month was 0.410. During the study period, the number of ICU beds increased only by 5% (from 133 in 2002-2005 to 140 in 2006 -2008) .
No change was observed during the study period in in-hospital mortality ( Data for long-term survival were available for Clalit's enrollees only (n ϭ 3999, 77.5% of patients) and are presented in Figure 2A . The proportion of patients surviving to hospital discharge in this subgroup was 44%. One-year, 2-, 5-, and 8-yr survival rates were 33%, 30%, 23%, and 20%, respectively. The overall standardized mortality ratio was 2078%, i.e., the observed number of deaths was 21fold higher than expected, after adjusting for age,
We conducted a landmark survival analysis for Clalit's enrollees surviving the acute sepsis episode (n ϭ 1770, 73% of patients surviving the acute sepsis episode, Fig. 2B ). The age-standardized 1-yr mortality for out-of-hospital survivors was compared to that of the general population of Clalit enrollees. One-year mortality rates for ages 18 -50 was 9% in survivors of sepsis compared to 0.11% in the general population (relative risk ϭ 80). For patients Ͼ80 yrs old, it was 42% in sepsis survivors and 4.5% in the general population (relative risk ϭ 9).
We compared long-term survival by age, sex, underlying comorbidities, Charlson comorbidity index, and the type and number of failing organ systems ( Figs. 3-5 ). Long-term mortality (up to 8 yrs) increased with increasing age (from 43% in patients younger than 50 yrs to 94% in those over 80 yrs, p Ͻ .001, Fig.  3 ). Mortality was similar among males and females (82% vs. 79%, respectively, p ϭ .925) and increased with higher Charlson comorbidity index (from 28% in patients with a score of 0 to 93% in those with a score of 6 or higher, p Ͻ .001, Fig.  4 ). When looking at specific underlying diagnoses, hazard ratios ranged from 1.19 for patients with diabetes (95% confidence interval 1.10Ϫ1.29), to 1. Patients with asthma had similar mortality rates as the overall cohort (hazard ratio ϭ 0.92, 95% confidence interval 0.76Ϫ1.10, p ϭ .33). Finally, mortality increased with a greater number of failing organ systems (from 60% in patients with no failing organs systems to 89% in those with three or more failing organ systems, p Ͻ .001, Fig. 5 
DISCUSSION
The present study describes the longterm outcome of patients with sepsis in the ICU in seven general hospitals in Israel from 2002 to 2008. The number of ICU admissions with sepsis increased by 37% over these years, while in-hospital mortality remained high and unchanged at approximately 56%. Long-term survival was poor, reaching 33%, 23%, and 20% over 1, 5, and 8 yrs, respectively. For certain subgroups, e.g., those older than 80 yrs, having a Charlson comorbidity index higher than 6, or having three failing systems or more, 8-yr survival was as low as 6%-11%.
The median age of patients in the present study was 70 yrs, much older than in some series (57-62 yrs in the studies by Angus et al [5] and Martin et al [8] ), but similar to the range reported by others (9, 19, 23) . Most patients (56%) were male, in accordance with some series (5, 19) but not with others (8, 9, 23) . Similar to other series (5, 7, 24) , the most common sites of infection were the lower respiratory tract, the urinary tract, and the peritoneal cavity. The patients in our study were much more likely to be diagnosed with certain comorbidities when compared with previously reported studies (5, 10, 19, (23) (24) (25) , including arterial hypertension (50% vs. 24%-35% in previously published series), ischemic heart disease (34% vs. 8%-23%), diabetes mellitus (33% vs. 12%-28%), chronic renal failure (25% vs. 5%-7%), and atrial fibrillation (26% vs. 10%) (5, 10, 19, (23) (24) (25) . The percentage of patients having no evidence of organ system dysfunction or one organ system dysfunction in the present study (9% and 31%, respectively) was much lower than previously reported, while those with three or more failing systems (28% of patients in the present study) were much more common than previously reported (5, 8, 19, 26, 27) . Martin et al (8) reported that 66%-83% had no evidence of organ system dysfunction and only 0.5%-2% had three or more failing organ systems. Other series (5, 19, 26, 27) focusing exclusively on patients with severe sepsis (i.e., with at least one failing organ system), reported that most patients (58%-81%) had one failing organ system and only 6%-16% had three or more failing organ systems. A possible explanation for these differences is the shortage of ICU beds in Israel, leading to a situation where only the sickest patients are admitted to the ICU. Of note, general medical and surgical wards in Israel treat patients requiring both invasive and noninvasive respiratory support as well as vasopressors (dopamine). It should also be noted that a do-not-resuscitate policy was not supported by the Israeli law at the time of the study and was not a reason for denying ICU admission.
A steady, linear, 37% increase in the mean number of admissions with sepsis per month was noted over the study period. Over that period, the number of ICU beds in hospitals included in the present study increased only by 5%. Health policy planners who look for data to guide resource allocation to optimize the use of ICU beds could use some of the data presented, showing very low long-term survival for patients older than 80 or with a high index of comorbidities.
While some of the increase in the number of sepsis cases is related to the aging of the population, including the rapid increase in the proportion of the very old, this fact alone could not account for the degree of increase noted. The prevalence of comorbidities related to sepsis (e.g., cancer, diabetes) is rising. Similar finding were previously reported in the United States (5, 8, 9, 26) , Spain (23), and Israel (28) .
The in-hospital mortality in our study (56%) was higher than reported in most other series, ranging from 34% to 43% in series focusing on ICUs (5, 11, 17, 20, 23, 24, 27, 29 -34) . No change over the study period was observed, in marked contrast with the literature, which clearly shows a trend for decreasing case-fatality rate over time (relative yearly decrease by 2%-5% in several studies) (8 -11) . Based on the current data, it is impossible to state whether the lack of decrease in the case-fatality rate stems from suboptimal adoption of specific strategies for treating sepsis (e.g., early goad-directed therapy [3] or recombinant human activated protein C [35] ), the general quality of care in the ICU (26) , or perhaps the low ratio of ICU-to-general medical beds in Israel, which is estimated at only 3%. This low ratio may lead to admitting only the sickest of the sick to the ICU. Israeli ICUs operate at full occupancy, therefore, admissions to the ICU can be delayed and patients are likely to be discharged too soon for the same reason. There are no step-down units in Israel. This means that the level of care drops precipitously when the patient moves to the general ward. In light of this shortage of ICU beds, the steady case-fatality rate despite the 37% increase in patient load is somewhat encouraging.
Hospital length of stay in the present study is quite long (median: 24 days) and may be related to the delayed discharge of patients with chronic illness, especially chronic critical illness, due to a shortage in long-term care facilities.
One-year mortality was 67%, similar to the previously reported range of 36%-72% (17, 20, 24, 27, 29, 31, 33, 34) . Oneyear mortality for out-of-hospital survivors was 21 times higher than expected based on data from the general Clalit's enrollees' population, after adjusting for age. This emphasizes the long-term sequelae of hospitalization with sepsis, although adjustment was limited by lack of data on comorbidities and underlying diagnoses of the general population.
Few studies reported on the long-term survival of sepsis patients (19, 20) . Cumulative mortality reported in the present study is within the range in previously published series (70% vs. 74%-76% at 5 yrs, 80% vs. 82% at 8 yrs following admission) (19, 20) . Similar to previous studies, poorer long-term survival was noted with increasing age, higher Charlson comorbidity index, and a greater number of failing organ systems (17, 19, 20) .
Several studies have addressed quality of life following sepsis admission (14 -18) . These patients have been reported to have persisting symptoms, such as dyspnea, fatigue, depression and functional decline (14, 15) , work-and daily activities-related difficulties, and overall lower perceived health (15) (16) (17) . A recently published prospective study (18) reported an increased incidence of new cognitive impairment, worsening of existing cognitive impairment, and an increase in functional disability among survivors of severe sepsis, compared with patients admitted for other reasons. These differences persisted for 8 yrs following sepsis admission. This important aspect lies beyond the scope of the present study.
Our study has several strengths, including the capture of a large percentage of the local population, the long-term follow-up (up to 8 yrs) with virtually no loss to follow-up for Clalit's enrollees, and the large sample size. This study adds to the knowledge base of health planners who are posed with hard choices in a situation where shortage of ICU beds is an issue.
Our study has several limitations relating to the inability to verify diagnostic codes for each case. Data regarding comorbidities and organ system failure were based on ICD-9-CM codes determined from physicians' diagnoses and are of limited precision. There is some potential overlap between the categories of comorbidities vs. organ system failure. Given the shortage of ICU beds, the proportion of patients without organ system failure (9%) might be an overestimate (presumably due to coding errors), these patients were unlikely to be admitted to the ICU. Similarly, the source of the infection could not be identified from ICD-9-CM codes in one third of patients. These difficulties are inherent to the administrative nature of the data. Another limitation is the inability to distinguish between community-and hospital-acquired sepsis, since the precise date of the diagnosis is unavailable; therefore, similarly to the previous studies (36), we do not know if the diagnosis was present at admission or developed during the patient's stay in the ICU. Therefore, we cannot reliably compare the outcome between patients directly admitted to the ICU and those who had delays getting in from the general medical and surgical wards, because we cannot distinguish between late nosocomial sepsis and delayed treatment of community-acquired sepsis. Data regarding severity of disease, such as the Acute Physiology and Chronic Health Evaluation II or Simplified Acute Physiology Score I scores, were not available in this administrative database. We also were unable to assess whether deaths were related to underlying comorbidities or to the acute event, although when comparing this cohort with the general population, the standardized mortality ratio was significantly elevated. Data regarding the therapies used (e.g., inotropes, vasopressors, antibiotics), timing of therapies, laboratory monitoring, and timing of the diagnosis of sepsis were not available. Laboratory results of central venous oxygen saturation, lactate, and other physiologic parameters (central venous pressure, mean arterial pressure) needed for monitoring the adherence to the goal-directed therapy were not recorded in the database. We were unable to determine whether these parameters were monitored more often over the course of the study and if treatment goals were met, and cannot correlate these with mortality trends.
CONCLUSION
To conclude, the number of ICU admissions with sepsis in Israel is rising. In-hospital and long-term mortality remains high, especially for the elderly and those with significant comorbidities or a larger number of failing organ systems. A severe shortage of ICU beds may be a contributing factor to these outcomes. More answers are needed regarding various aspects of care for patients with sepsis and these could be addressed by a future prospective study we plan to perform.
